ArticleCancer chemotherapy and pharmacology2014

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).

Tadahiro Shoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.